key: cord-0884722-h2ezy4f8
authors: Bernabeu-Wittel, M.; Ternero-Vega, J.E.; Díaz-Jiménez, P.; Conde-Guzmán, C.; Nieto-Martín, M.D.; Moreno-Gaviño, L.; Delgado-Cuesta, J.; Rincón-Gómez, M.; Giménez-Miranda, L.; Navarro-Amuedo, M.D.; Muñoz-García, M.M.; Calzón-Fernández, S.; Ollero-Baturone, M.
title: DEATH RISK STRATIFICATION IN ELDERLY PATIENTS WITH COVID-19. A COMPARATIVE COHORT STUDY IN NURSING HOMES OUTBREAKS
date: 2020-08-25
journal: Arch Gerontol Geriatr
DOI: 10.1016/j.archger.2020.104240
sha: 443505cdb64c8dfbcabe4c8ce69b31024e5cb6cb
doc_id: 884722
cord_uid: h2ezy4f8

Elderly people are more severely affected by COVID-19. Nevertheless scarce information about specific prognostic scores for this population is available. The main objective was to compare the accuracy of recently developed COVID-19 prognostic scores to that of CURB-65, Charlson and PROFUND indices in a cohort of 272 elderly patients from four nursing homes, affected by COVID-19. Accuracy was measured by calibration (calibration curves and Hosmer-Lemeshov (H-L) test), and discriminative power (area under the receiver operation curve (AUC-ROC). Negative and positive predictive values (NPV and PPV) were also obtained. Overall mortality rate was 22.4%. Only ACP and Shi et al. out of 10 specific COVID-19 indices could be assessed. All indices but CURB-65 showed a good calibration by H-L test, whilst PROFUND, ACP and CURB-65 showed best results in calibration curves. Only CURB-65 (AUC-ROC = 0.81 [0.75 to 0.87])) and PROFUND (AUC-ROC = 0.67 [0.6 to 0.75])) showed good discrimination power. The highest NPV was obtained by CURB-65 (95% [90 to 98%]), PROFUND (93% [77to 98%]), and their combination (100% [82 to 100%]); whereas CURB-65 (74% [51 to 88%]), and its combination with PROFUND (80% [50 to 94%]) showed highest PPV. PROFUND and CURB-65 indices showed the highest accuracy in predicting death-risk of elderly patients affected by COVID-19, whereas Charlson and recent developed COVID-19 specific tools lacked it, or were not available to assess. A comprehensive clinical stratification on two-level basis (basal death risk due to chronic conditions by PROFUND index, plus current death risk due to COVID-19 by CURB-65), could be an appropriate approach.

Highlights. Main results, conclusions and recommendations of death-risk prediction in elderly patients living in nursing homes, with COVID-19.

-Elderly people living in nursing-homes are at high-risk of suffering COVID-19.

-Scarce information about their death-risk scoring is available to guide clinicians' decisions.

-Accuracy of COVID-19 prognostic scores, CURB-65, Charlson and PROFUND were assessed.

-CURB-65 and PROFUND showed the highest accuracy.

-Charlson and COVID-19 specific tools lacked enough accuracy for this population.

-Stratifying on a two-axis basis by PROFUND and CURB-65 could be a reasonable approach for elderly people living in nursing-homes.

The recent pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) around the world has put aged people in front of a devastating horizon. As a matter of fact they make up around 30% of all cases, 45-50% of all hospitalizations, and 80% of all deaths [1] [2] [3] . In these age strata SARS-CoV-2 disease (COVID-19) lethality rate can reach up to 50% [2, 3] . This increased mortality may be explained in part by already known risk factors (frailty, infection acting as a trigger to decompensate other chronic conditions, immunosenescense, and development of geriatric syndromes' cascade) [4] ; but in the actual world's alarm context, there are other evident or subtle reasons, like health-care systems collapse, lack of material and human resources, and disaster situations involving ethical issues, which are contributing to this poor results [5] [6] [7] [8] [9] .

In addition, data about prognostic factors and accurate tools to predict COVID-19

patients' outcomes are scarce [10] . In a recent review, authors identified 10 prognostic indices, most of them poorly reported, at high risk of bias, and with suboptimal described performance [11] . Having reliable prognostic tools is even more critical in the elderly, because their mortality is highest. In these populations it is our duty to avoid nihilism, offering best aggressive choices to those with good life expectancy; but also to avoid futility, offering best palliative care to those already in their end-of-life trajectory [12] [13] [14] .

The significance of co-morbidities in the outcome of multiple acute diseases has largely been demonstrated [15] [16] [17] [18] . Nevertheless, in most initial series of COVID-19, the impact of underlying chronic conditions in morbidity and mortality has been only partially analyzed, whereas most focus had been put in acute symptoms and laboratory parameters [3] .

However, in a recent large multicenter cohort of patients with COVID-19, chronic cardiac disease, non-asthmatic chronic pulmonary disease, chronic kidney disease, liver disease and obesity were associated with higher in-hospital mortality [19] . In this sense, there are already developed and contrasted prognostic tools centered on patients' co-morbidities like the classic Charlson index, or the PROFUND index specifically developed for patients with J o u r n a l P r e -p r o o f multimorbidity and polypathology, which could be used to assess death-risk of elderly and vulnerable populations [20, 21] . In addition there are also simple and already contrasted tools to stratify death risk of patients with pneumonia, like CURB-65 [22] In the present work we have analyzed the predictive power of various prognostic tools specifically developed for COVID-19 in a multicenter cohort of elderly patients living in nursing homes and affected with COVID-19, and compared it to that of CURB-65 and two extensively used co-morbidity indices (Charlson and PROFUND), in order to know the best choice for death risk stratification in the attention to this vulnerable population.

This was a retrospective cohort study including all patients affected by COVID-19 from four nursing homes sizeable outbreaks, which occurred during March and April 2020 in the city of Seville, southern Spain.

Reference population and inclusion criteria: The total population of the 4 nursing homes was 457 residents (median age of 86 years-old [Quartile1-Quartile3 (Q1-Q3)=79-91], 75% women). All residents diagnosed with COVID-19 were included in the present study. Patients management, follow-up, and discharge: A coordinated on-site medicalization program was quickly built to offer best clinical care to affected residents. All patients were attended following a common clinical management, treatment algorithm, hospital referral criteria, and were followed-up accordingly until recovery or death. Clinical recovery was defined after three days of being asymptomatic, and microbiological cure when the patient tested a control negative nasopharyngeal swab PCR after clinical cure. For the purposes of this study a 30-day period after SARS-CoV-2 infection confirmation was established.

Functional and death-risk indices: The Barthel index was used to measure the fitness in activities of daily living [23] . The assessment of co-morbidities global weight in determining death risk was analyzed with the Charlson and PROFUND indices [20, 21] . We selected CURB-65 score for the specific stratification of death risk in patients with pneumonia because of its demonstrated accuracy and easiness to use [22] . Respecting newly developed scores specifically designed to assess death-risk of patients with COVID-19, we tested ACP and Shi et al. indices [24, 25] . Other recently developed scores could not be calculated because single dimensions' weighing of scores' variables were not available to use (Caramelo et al., COVID-19 vulnerability index, Surgisphere mortalitiy risk tool [26] [27] [28] ); the output of death-risk was individually established for every dimension, but with no global risk assessment (COVID-19 prognostic tool [29] ); dimensions were quantitatively accounted but the model equations were not available to use (Xie et al. [30] ); or inclusion of computerized tomography (CT) regarding the protection of persons and their personal data. Missing data were replaced by single imputation techniques. In order to provide best quality and transparency of data description we followed STROBE and STARD recommendations and check-list [34, 35] .

In total 272 residents affected with COVID-19 were included (59.5% of the whole population). The main clinical features and different risk indices average scores are detailed in Table 1 . The cohort was composed mainly by elderly women, with multiple chronic conditions, vulnerability, and functional impairment. Most frequent symptoms were fatigue and global deterioration, low grade fever, dyspnea, and cough; and biological parameters alterations were similar to those already known to be associated to COVID-19. The scores of all indices were high, thereby determining a high death risk in the whole cohort of patients.

Overall mortality rate was 22.4% (61 patients). A flowchart of the whole study is detailed in Supplementary Appendix, Figure 1 . The calibration of all studied indices is detailed in Table 2 Table S1 . The decision threshold plots with the calculated Youden index are detailed in Supplementary appendix Figure S8 , and Table S2 .

Assessment of S, E, NPV, and PPV of all indices is detailed in Table 3 . and PPV (80%), respectively.

PROFUND index was originally developed and validated to predict 12-month mortality in hospital-based patients with multimorbidity, but its generalizability has been established later by means of historical, geographic, spectrum, and follow-up transportability (in primary care polypathological patients, in other geographical areas, in patients with heart failure, and in shorter (predicting hospitalization episode mortality) and longer (four years) periods of follow-up) [36] [37] [38] [39] [40] . Recently a systematic revision of prognostic indices in patients with multimorbidity catalogued it as of satisfactory quality among other 35 evaluated tools [41] . The different mortality risks among its strata, with respect those risks originally published are logical, because in the present study the end point was survival to the acute episode of COVID-19, whereas the original end point was 12-months survival; nevertheless in the present study we obtained a similar accuracy as that originally reported, and later validated in other populations [21, [36] [37] [38] [39] [40] . Its main limitation may be the absence of any features due to the acute disease, which are important in predicting the short-term outcomes of all acute events. Based on the results of the present study (excellent calibration, significant differentiated trajectories among the four risk groups, and good discrimination power), PROFUND index could be an appropriate tool to assess the basal death risk due to chronic conditions, of frail elderly patients affected by COVID-19.

In present days, CURB-65 index is probably the most used prognostic tool in patients with pneumonia [42] [43] [44] [45] . Its accuracy in many different populations in addition with its easier and simpler calculation with respect to others, explain this fact [42] [43] [44] [45] . In the present study we obtained a similar accuracy as previously described [42] [43] [44] [45] . In previous reports, there has been some concern regarding its PPV [42] ; but in the present study, the highest risk group of CURB-65 and its combination with the same risk group of PROFUND index, showed a notably high PPV. In addition, an early and evident separation in its risk-strata trajectories in Kaplan-Meier curves was evident, conferring it therefore an early prediction power in mortality risk. Its main limitation may be the absence of any features regarding chronic conditions and global basal patient's status (functional, mental and sociofamiliar); in spite of the demonstrated important prognostic weight of these variables in elderly populations [20, 21] . Based on the results of the present study (acceptable calibration, significant differentiated trajectories among the four risk groups, and excellent discrimination power), CURB-65 index could be an appropriate tool to assess the current death risk of this population due to COVID-19 severity.

Charlson index obtained poor results, even using its version adjusted by age. We have also detected this fact in comparisons performed with other current indices [21, 46] . We are aware and agree about its historical value (it was pioneer, and could be considered even legendary), but nowadays we have serious concerns regarding its precision (calibration and discrimination power). The index only considers chronic diseases, but not other important parameters like functional measures or geriatric associated conditions. As a matter of fact, according to its dimensions' relative weights, Charlson index systematically overestimate death risk.

With respect to the recent indices specifically developed for COVID-19, finally we could analyze only two of them, because of different reasons. In some of them the weights of their dimensions were not available, other did not put out the global death risk, and some of J o u r n a l P r e -p r o o f them included dimensions, which are not routinely performed in these population (like CT scans) [26] [27] [28] [29] [30] [31] [32] [33] . In addition most of them are not yet published after peer review [24] [25] [26] [27] [28] [29] [30] [31] [32] . ACP index includes only age and C-reactive protein, and Shi et al. index only age, sex and hypertension as predictors; these variable packages showed being insufficient to predict mortality in a frail aged population with multimorbidity, in which other important aspects should be accounted. This is the most plausible explanation for the lack of precision of these indices with respect to that of PROFUND and CURB-65, which do take into account these important aspects in aging populations. This study has some limitations, that should be remarked. The results could be limited by the number of patients, but on the other hand the cohort was homogeneous and probably J o u r n a l P r e -p r o o f represents adequately nursing homes' populations. Additionally, the retrospective collection of the cohort's data, could introduce some errors or biases, but for the purpose of the present study, this issue may be of less significance (deaths as end-point are difficult to get unnoticed, and all the remaining variables are normally available in most patients). Finally, only two recently developed COVID-19 prognostic scores could be compared with the other chosen tools due to the lack of required information needed for the specified data analysis.

In conclusion, the combination of PROFUND and CURB-65 indices showed the highest accuracy in predicting death-risk of elderly patients living in nursing-homes and affected by COVID-19, whereas Charlson index and recent developed COVID-19 specific tools lacked it, or were not available to assess. A comprehensive clinical approach stratifying these patients on a two-level basis (basal death risk due to chronic conditions by PROFUND index, plus current death risk due to COVID-19 by CURB-65), could be appropriate. Transparency declaration: The lead author affirms that this manuscript is an honest, accurate, and transparent account of the study being reported; that no important aspects of the study have been omitted; and that any discrepancies from the study as planned (and, if relevant, registered) have been explained.

Funding source: No funding source has been present in the development of the present work. 

Our support and affection to all residents, their families and the nursing homes' staff members for their collaboration, patience and resilience. Special thanks to all members of Primary Care and Hospital COVID teams listed below, and health managers who have worked so hard to heal and alleviate patients and their families

Susana Padrones (Manager and Medical Director of Primary Care District of Seville)

César Sotomayor, Raquel Valencia (Infectious Diseases, Microbiology, and Epidemiology and Preventive Medicine Department

Report on the situation of COVID-19 in Spain

Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) -United States

Clinical characteristics of 312 hospitalized older patients with COVID-19 in Wuhan, China

Immunosenescence exacerbates the COVID-19

Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response

Mar 13 (Epub ahead of print)

Calculated decisions: COVID-19 calculators during extreme resource-limited situations

Ethics of reallocating ventilators in the covid-19 pandemic

Facing Covid-19 in Italy -Ethics, Logistics, and Therapeutics on the Epidemic's Front Line

Whose life to save? Scarce resources allocation in the COVID-19 outbreak

Sharing research data and findings relevant to the novel coronavirus (COVID-19) outbreak 2020

Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal

Clinical characteristics of older patients infected with COVID-19: A descriptive study

COVID-19 pandemic: palliative care for elderly and frail patients at home and in residential and nursing homes

For The Covid-Task Force Of Palliative Ch

COVID-19: decision making and palliative care

The importance of co-existing disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement

The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus

Non-cardiac comorbidities in chronic heart failure

Common comorbidity scales were similar in their ability to predict health care cost and mortality

Features of 20133 UK Patients in Hospital With COVID-19 Using the ISARIC WHO Clinical Characterisation Protocol: Prospective Observational Cohort Study

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Development of a new predictive model for polypathological patients. The PROFUND index

Defining Community Acquired Pneumonia Severity on Presentation to Hospital: An International Derivation and Validation Study

Functional evaluation: The Barthel Index

ACP risk grade: a simple mortality index for patients with confirmed or suspected severe acute respiratory syndrome coronavirus 2 disease (COVID-19) during the early stage of outbreak in Wuhan

Host susceptibility to severe COVID-19 and establishment of a host risk score: findings of 487 cases outside Wuhan

Estimation of risk factors for COVID-19 mortalitypreliminary results

COVID-19 Mortality Risk Calculator

COVID-19 Prognostic Tool

Development and external validation of a prognostic multivariable model on admission for hospitalized patients with

Predicting COVID-19 malignant progression with AI techniques

Machine learning-based CT radiomics model for predicting hospital stay in patients with pneumonia associated with SARS-CoV-2 infection: a multicenter study

Association of radiologic findings with mortality of patients infected with 2019 novel coronavirus in Wuhan, China

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) sta tement: guidelines for reporting observational studies; STROBE Initiative

For the STARD Group. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies

Validation of a prognostic model for polypathological patients (PP) in Primary Health Care: PROFUND STUDY-AP

Validation of PROFUND prognostic index over a four-year followup period

External validation of the PROFUND index in polypathological patients from internal medicine and acute geriatrics departments in Aragón

Prevalence of comorbidities and the prognostic value of the PROFUND index in a hospital cardiology unit

Validation of the PROFUND index to predict early post-hospital discharge mortality

Measuring multimorbidity beyond counting diseases: systematic review of community and J o u r n a l P r e -p r o o f population studies and guide to index choice

Value of severity scales in predicting mortality from community-acquired pneumonia: systematic review and meta-analysis

Performance of CURB-65 and CURB-age in community-acquired pneumonia

The value of prognostic indices for pneumonia

Disease severity prediction for nursing home-acquired pneumonia in the emergency department

Development of a six-month prognostic index in patients with advanced chronic medical conditions: the PALIAR score

PROFUND 0-2 points 97%

PROFUND ≥11 points 52%

CURB-65 ≥4 points 23%

Charlson 0 points 77%

Charlson ≥5 points 15%

AA Charlson 0-3 points* 94%

AA Charlson ≥5 points 80%

ACP 0-1 points# 96%

ACP =3 points 92%

PROFUND ≥11 points and CURB-65 ≥4 points 13%

AA: Adjusted by age; *There were no patients with a score ranging of 0-1 points and only 5 patients with 2 points; #There was only one patient with 0 points in the score; &There were no patients with 0 points in the score. cohort of nursing home residents with COVID-19 in

J o u r n a l P r e -p r o o f